Skip to main content
Top
Published in: Infection 5/2011

01-10-2011 | Clinical and Epidemiological Study

Evaluation of potential biomarkers for the discrimination of bacterial and viral infections

Authors: P. Chalupa, O. Beran, H. Herwald, N. Kaspříková, M. Holub

Published in: Infection | Issue 5/2011

Login to get access

Abstract

Purpose

Timely knowledge of the bacterial etiology and localization of infection are important for empirical antibiotic therapy. Thus, the goal of this study was to evaluate routinely used biomarkers together with novel laboratory parameters in the diagnosis of infection.

Methods

In this prospective study, 54 adult patients with bacterial infections admitted to the Department of Infectious Diseases were included. For comparison, 27 patients with viral infections were enrolled. In these patients, white blood cell (WBC) counts, differential blood counts, serum levels of procalcitonin (PCT), IL-1β, IL-6, IL-8, IL-10, IL-12, TNF-α, IFN-γ, soluble CD14 (sCD14), heparin-binding protein (HBP), cortisol (Cort), and monocyte surface expression of TLR2, TLR4, HLA-DR, and CD14 were analyzed. Also, these biomarkers were evaluated in 21 patients with acute community-acquired bacterial pneumonia (CABP), as well as in 21 patients with pyelonephritis and urosepsis.

Results

The highest sensitivity and specificity (expressed as the area under the curve [AUC]) for bacterial infection were observed in serum concentration of PCT (0.952), neutrophil and lymphocyte counts (0.852 and 0.841, respectively), and serum levels of HBP (0.837), IL-6 (0.830), and Cort (0.817). In addition, the serum levels of IFN-γ and Cort were significantly higher and IL-8 levels were lower in CABP when compared to pyelonephritis or urosepsis.

Conclusions

From the novel potential biomarkers, only PCT demonstrated superiority over the routine parameters in the differentiation of bacterial from viral infections. However, some of the novel parameters should be further evaluated in larger and better characterized cohorts of patients in order to find their clinical applications.
Literature
1.
go back to reference Adams NG. Diagnostic use of C-reactive protein in bacteraemic emergency department patients. Emerg Med Australas. 2005;17:371–5.PubMedCrossRef Adams NG. Diagnostic use of C-reactive protein in bacteraemic emergency department patients. Emerg Med Australas. 2005;17:371–5.PubMedCrossRef
2.
go back to reference Klein JO. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization. Pediatr Infect Dis J. 2002;21:584–8. Discussion 613–4.PubMedCrossRef Klein JO. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization. Pediatr Infect Dis J. 2002;21:584–8. Discussion 613–4.PubMedCrossRef
3.
go back to reference Ho KM, Lipman J. An update on C-reactive protein for intensivists. Anaesth Intensive Care. 2009;37:234–41.PubMed Ho KM, Lipman J. An update on C-reactive protein for intensivists. Anaesth Intensive Care. 2009;37:234–41.PubMed
4.
go back to reference Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;34:515–8.CrossRef Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;34:515–8.CrossRef
5.
go back to reference Huang SY, Tang RB, Chen SJ, Chung RL. Serum interleukin-6 level as a diagnostic test in children with sepsis. J Chin Med Assoc. 2003;66:523–7.PubMed Huang SY, Tang RB, Chen SJ, Chung RL. Serum interleukin-6 level as a diagnostic test in children with sepsis. J Chin Med Assoc. 2003;66:523–7.PubMed
6.
go back to reference Russell JA. Management of sepsis. N Engl J Med. 2006;355:1669–713. Erratum in: N Engl J Med. 2006;355:2267.CrossRef Russell JA. Management of sepsis. N Engl J Med. 2006;355:1669–713. Erratum in: N Engl J Med. 2006;355:2267.CrossRef
7.
go back to reference Kim D, Reilly A, Lawrence DA. Relationships between IFN gamma, IL-6, corticosterone, and Listeria monocytogenes pathogenesis in BALB/c mice. Cell Immunol. 2001;207:13–8.PubMedCrossRef Kim D, Reilly A, Lawrence DA. Relationships between IFN gamma, IL-6, corticosterone, and Listeria monocytogenes pathogenesis in BALB/c mice. Cell Immunol. 2001;207:13–8.PubMedCrossRef
8.
go back to reference Linder A, Christensson B, Herwald H, Björck L, Akesson P. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis. 2009;49:1044–50.PubMedCrossRef Linder A, Christensson B, Herwald H, Björck L, Akesson P. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis. 2009;49:1044–50.PubMedCrossRef
9.
go back to reference Cheadle WG. The human leukocyte antigens and their relationship to infection. Am J Surg. 1993;165:75S–81S.PubMedCrossRef Cheadle WG. The human leukocyte antigens and their relationship to infection. Am J Surg. 1993;165:75S–81S.PubMedCrossRef
10.
go back to reference Härter L, Mica L, Stocker R, Trentz O, Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock. 2004;22:403–9.PubMedCrossRef Härter L, Mica L, Stocker R, Trentz O, Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock. 2004;22:403–9.PubMedCrossRef
11.
go back to reference Kragsbjerg P, Jones I, Vikerfors T, Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax. 1995;50:1253–7.PubMedCrossRef Kragsbjerg P, Jones I, Vikerfors T, Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax. 1995;50:1253–7.PubMedCrossRef
12.
go back to reference Nanda N, Juthani-Mehta M. Novel biomarkers for the diagnosis of urinary tract infection—a systematic review. Biomark Insights. 2009;4:111–21.PubMed Nanda N, Juthani-Mehta M. Novel biomarkers for the diagnosis of urinary tract infection—a systematic review. Biomark Insights. 2009;4:111–21.PubMed
13.
go back to reference Huang DT, Huang FY, Tsai TC, Tsai JD, Chiu NC, Lin CC. Clinical differentiation of acute pyelonephritis from lower urinary tract infection in children. J Microbiol Immunol Infect. 2007;40:513–7.PubMed Huang DT, Huang FY, Tsai TC, Tsai JD, Chiu NC, Lin CC. Clinical differentiation of acute pyelonephritis from lower urinary tract infection in children. J Microbiol Immunol Infect. 2007;40:513–7.PubMed
14.
go back to reference Costa Orvay JA, Caritg Bosch J, Morillo Palomo A, Noguera Julián T, Esteban Torne E, Palomeque Rico A. Toxic shock syndrome: experience in a pediatric intensive care unit. An Pediatr (Barc). 2007;66:566–72.CrossRef Costa Orvay JA, Caritg Bosch J, Morillo Palomo A, Noguera Julián T, Esteban Torne E, Palomeque Rico A. Toxic shock syndrome: experience in a pediatric intensive care unit. An Pediatr (Barc). 2007;66:566–72.CrossRef
15.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.PubMedCrossRef Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.PubMedCrossRef
16.
go back to reference Tapper H, Karlsson A, Mörgelin M, Flodgaard H, Herwald H. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood. 2002;99:1785–93.PubMedCrossRef Tapper H, Karlsson A, Mörgelin M, Flodgaard H, Herwald H. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood. 2002;99:1785–93.PubMedCrossRef
17.
go back to reference Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13:R83.PubMedCrossRef Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13:R83.PubMedCrossRef
18.
go back to reference Stankovic Stojanovic K, Steichen O, Lionnet F, Bachmeyer C, Lecomte I, Avellino V, Grateau G, Girot R, Lefevre G. Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis? Infection. 2011;39:41–5.PubMedCrossRef Stankovic Stojanovic K, Steichen O, Lionnet F, Bachmeyer C, Lecomte I, Avellino V, Grateau G, Girot R, Lefevre G. Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis? Infection. 2011;39:41–5.PubMedCrossRef
19.
go back to reference Mills GD, Lala HM, Oehley MR, Craig AB, Barratt K, Hood D, Thornley CN, Nesdale A, Manikkam NE, Reeve P. Elevated procalcitonin as a diagnostic marker in meningococcal disease. Eur J Clin Microbiol Infect Dis. 2006;25:501–9.PubMedCrossRef Mills GD, Lala HM, Oehley MR, Craig AB, Barratt K, Hood D, Thornley CN, Nesdale A, Manikkam NE, Reeve P. Elevated procalcitonin as a diagnostic marker in meningococcal disease. Eur J Clin Microbiol Infect Dis. 2006;25:501–9.PubMedCrossRef
20.
go back to reference Müller B, Schuetz P, Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents. 2007;30:S16–23.PubMedCrossRef Müller B, Schuetz P, Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents. 2007;30:S16–23.PubMedCrossRef
21.
go back to reference Beran O, Herwald H, Dzupová O, Chalupa P, Holub M. Heparin-binding protein as a biomarker of circulatory failure during severe infections: a report of three cases. Scand J Infect Dis. 2010;42:634–6.PubMedCrossRef Beran O, Herwald H, Dzupová O, Chalupa P, Holub M. Heparin-binding protein as a biomarker of circulatory failure during severe infections: a report of three cases. Scand J Infect Dis. 2010;42:634–6.PubMedCrossRef
22.
go back to reference Lannergård A, Viberg A, Cars O, Karlsson MO, Sandström M, Larsson A. The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy. Scand J Infect Dis. 2009;41:663–71.PubMedCrossRef Lannergård A, Viberg A, Cars O, Karlsson MO, Sandström M, Larsson A. The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy. Scand J Infect Dis. 2009;41:663–71.PubMedCrossRef
23.
go back to reference Noor MK, Shahidullah M, Mutanabbi M, Barua C, Mannan MA, Afroza S. Comparison between CRP and IL-6 as early markers of neonatal sepsis. Mymensingh Med J. 2008;17:S72–6.PubMed Noor MK, Shahidullah M, Mutanabbi M, Barua C, Mannan MA, Afroza S. Comparison between CRP and IL-6 as early markers of neonatal sepsis. Mymensingh Med J. 2008;17:S72–6.PubMed
24.
go back to reference Holub M, Beran O, Dzupová O, Hnyková J, Lacinová Z, Príhodová J, Procházka B, Helcl M. Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Crit Care. 2007;11:R41.PubMedCrossRef Holub M, Beran O, Dzupová O, Hnyková J, Lacinová Z, Príhodová J, Procházka B, Helcl M. Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Crit Care. 2007;11:R41.PubMedCrossRef
25.
go back to reference de Aguiar BB, Girardi I, Paskulin DD, de Franca E, Dornelles C, Dias FS, Bonorino C, Alho CS. CD14 expression in the first 24 h of sepsis: effect of -260C > T CD14 SNP. Immunol Incest. 2008;37:752–69.CrossRef de Aguiar BB, Girardi I, Paskulin DD, de Franca E, Dornelles C, Dias FS, Bonorino C, Alho CS. CD14 expression in the first 24 h of sepsis: effect of -260C > T CD14 SNP. Immunol Incest. 2008;37:752–69.CrossRef
26.
go back to reference Aalto H, Takala A, Kautiainen H, Siitonen S, Repo H. Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection. Scand J Infect Dis. 2007;39:596–603.PubMedCrossRef Aalto H, Takala A, Kautiainen H, Siitonen S, Repo H. Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection. Scand J Infect Dis. 2007;39:596–603.PubMedCrossRef
27.
go back to reference Rothfuchs AG, Kreuger MR, Wigzell H, Rottenberg ME. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. J Immunol. 2004;172:2407–15.PubMed Rothfuchs AG, Kreuger MR, Wigzell H, Rottenberg ME. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. J Immunol. 2004;172:2407–15.PubMed
28.
go back to reference O’Brien JM Jr, Abraham E. Human models of endotoxemia and recombinant human activated protein C. Crit Care Med. 2004;32:S202–8.PubMedCrossRef O’Brien JM Jr, Abraham E. Human models of endotoxemia and recombinant human activated protein C. Crit Care Med. 2004;32:S202–8.PubMedCrossRef
29.
go back to reference Unsinger J, Kazama H, McDonough JS, Hotchkiss RS, Ferguson TA. Differential lymphopenia-induced homeostatic proliferation for CD4(+) and CD8(+) T cells following septic injury. J Leukoc Biol. 2009;85:382–90.PubMedCrossRef Unsinger J, Kazama H, McDonough JS, Hotchkiss RS, Ferguson TA. Differential lymphopenia-induced homeostatic proliferation for CD4(+) and CD8(+) T cells following septic injury. J Leukoc Biol. 2009;85:382–90.PubMedCrossRef
30.
go back to reference Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009;37:2746–52.PubMedCrossRef Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009;37:2746–52.PubMedCrossRef
31.
go back to reference Jansen PM, van der Pouw Kraan TC, de Jong IW, van Mierlo G, Wijdenes J, Chang AA, Aarden LA, Taylor FB Jr, Hack CE. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. Blood. 1996;87:5144–51.PubMed Jansen PM, van der Pouw Kraan TC, de Jong IW, van Mierlo G, Wijdenes J, Chang AA, Aarden LA, Taylor FB Jr, Hack CE. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. Blood. 1996;87:5144–51.PubMed
Metadata
Title
Evaluation of potential biomarkers for the discrimination of bacterial and viral infections
Authors
P. Chalupa
O. Beran
H. Herwald
N. Kaspříková
M. Holub
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 5/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0126-4

Other articles of this Issue 5/2011

Infection 5/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.